The main prognostic factors for glioblastoma (GBM) are age, performance status, histologic grade, and the presence of specific molecular markers, such as MGMT methylation, IDH1/2 mutations, 1p19q codeletion, and EGFR overexpression, according to a new classification. Here, IDH1 is linked to glioblastoma.